{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T21:13:28Z","timestamp":1788556408770,"version":"build-2803163510"},"reference-count":56,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007520","name":"Nationwide Children&apos;s Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007520","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011500","name":"Abigail Wexner Research Institute at Nationwide Children&apos;s Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011500","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Advances"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.omta.2026.201687","type":"journal-article","created":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T16:37:20Z","timestamp":1770482240000},"page":"201687","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Autophagy activation via BAG3 gene therapy improves phenotype in a mouse model of LGMD1A"],"prefix":"10.1016","volume":"34","author":[{"given":"Burcak","family":"Ozes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingying","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle","family":"Moss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Myers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilye","family":"Morrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatyana A.","family":"Vetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2974-3943","authenticated-orcid":false,"given":"Zarife","family":"Sahenk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omta.2026.201687_bib1","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1093\/hmg\/9.14.2141","article-title":"Myotilin is mutated in limb girdle muscular dystrophy 1A","volume":"9","author":"Hauser","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omta.2026.201687_bib2","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1212\/01.WNL.0000123576.74801.75","article-title":"Mutations in myotilin cause myofibrillar myopathy","volume":"62","author":"Selcen","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.omta.2026.201687_bib3","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.nmd.2011.05.002","article-title":"Clinical and myopathological evaluation of early- and late-onset subtypes of myofibrillar myopathy","volume":"21","author":"Olive","year":"2011","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.omta.2026.201687_bib4","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/hmg\/8.7.1329","article-title":"Myotilin, a novel sarcomeric protein with two Ig-like domains, is encoded by a candidate gene for limb-girdle muscular dystrophy","volume":"8","author":"Salmikangas","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omta.2026.201687_bib5","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/hmg\/ddg020","article-title":"Myotilin, the limb-girdle muscular dystrophy 1A (LGMD1A) protein, cross-links actin filaments and controls sarcomere assembly","volume":"12","author":"Salmikangas","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omta.2026.201687_bib6","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1242\/jcs.02484","article-title":"The Z-disc proteins myotilin and FATZ-1 interact with each other and are connected to the sarcolemma via muscle-specific filamins","volume":"118","author":"Gontier","year":"2005","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.omta.2026.201687_bib7","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1128\/MCB.01454-08","article-title":"A class III PDZ binding motif in the myotilin and FATZ families binds enigma family proteins: a common link for Z-disc myopathies","volume":"29","author":"von Nandelstadh","year":"2009","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.omta.2026.201687_bib8","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1083\/jcb.151.2.235","article-title":"Indications for a novel muscular dystrophy pathway. gamma-filamin, the muscle-specific filamin isoform, interacts with myotilin","volume":"151","author":"van der Ven","year":"2000","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.omta.2026.201687_bib9","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/B978-0-08-045031-5.00011-6","article-title":"Myofibrillar myopathies","volume":"101","author":"Selcen","year":"2011","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.omta.2026.201687_bib10","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/brain\/awh576","article-title":"Myotilinopathy: refining the clinical and myopathological phenotype","volume":"128","author":"Olive","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.omta.2026.201687_bib11","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1042\/BJ20101672","article-title":"Analysis of myotilin turnover provides mechanistic insight into the role of myotilinopathy-causing mutations","volume":"436","author":"von Nandelstadh","year":"2011","journal-title":"Biochem. J."},{"key":"10.1016\/j.omta.2026.201687_bib12","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/embor.2010.203","article-title":"BAG3 mediates chaperone-based aggresome-targeting and selective autophagy of misfolded proteins","volume":"12","author":"Gamerdinger","year":"2011","journal-title":"EMBO Rep."},{"key":"10.1016\/j.omta.2026.201687_bib13","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.tips.2016.04.007","article-title":"Breaking BAG: The Co-Chaperone BAG3 in Health and Disease","volume":"37","author":"Behl","year":"2016","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.omta.2026.201687_bib14","doi-asserted-by":"crossref","first-page":"E7043","DOI":"10.1073\/pnas.1803130115","article-title":"Hsp70-Bag3 complex is a hub for proteotoxicity-induced signaling that controls protein aggregation","volume":"115","author":"Meriin","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omta.2026.201687_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016828","article-title":"BAG3 directly interacts with mutated alphaB-crystallin to suppress its aggregation and toxicity","volume":"6","author":"Hishiya","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.omta.2026.201687_bib16","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1093\/hmg\/ddl160","article-title":"Transgenic mice expressing the myotilin T57I mutation unite the pathology associated with LGMD1A and MFM","volume":"15","author":"Garvey","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omta.2026.201687_bib17","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1038\/gt.2008.104","article-title":"Construction and analysis of compact muscle-specific promoters for AAV vectors","volume":"15","author":"Wang","year":"2008","journal-title":"Gene Ther."},{"key":"10.1016\/j.omta.2026.201687_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24098456","article-title":"Protein Aggregates and Aggrephagy in Myopathies","volume":"24","author":"Gibertini","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omta.2026.201687_bib19","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1146\/annurev-pathmechdis-012419-032618","article-title":"Autophagy Defects in Skeletal Myopathies","volume":"15","author":"Margeta","year":"2020","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.omta.2026.201687_bib20","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1080\/15548627.2020.1833500","article-title":"Metformin rescues muscle function in BAG3 myofibrillar myopathy models","volume":"17","author":"Ruparelia","year":"2021","journal-title":"Autophagy"},{"key":"10.1016\/j.omta.2026.201687_bib21","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.029938","article-title":"Dysregulated Autophagy and Sarcomere Dysfunction in Patients With Heart Failure With Co-Occurrence of P63A and P380S BAG3 Variants","volume":"12","author":"Martin","year":"2023","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.omta.2026.201687_bib22","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.4103\/NRR.NRR-D-24-00517","article-title":"Small heat shock protein B8: from cell functions to its involvement in diseases and potential therapeutic applications","volume":"20","author":"Chierichetti","year":"2025","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.omta.2026.201687_bib23","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3389\/fnmol.2017.00176","article-title":"The Role of the Heat Shock Protein B8 (HSPB8) in Motoneuron Diseases","volume":"10","author":"Rusmini","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.omta.2026.201687_bib24","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3389\/fnmol.2017.00177","article-title":"The Role of the Multifunctional BAG3 Protein in Cellular Protein Quality Control and in Disease","volume":"10","author":"Sturner","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.omta.2026.201687_bib25","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0960-9822(01)00487-0","article-title":"Cooperation of a ubiquitin domain protein and an E3 ubiquitin ligase during chaperone\/proteasome coupling","volume":"11","author":"Demand","year":"2001","journal-title":"Curr. Biol."},{"key":"10.1016\/j.omta.2026.201687_bib26","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1379\/1466-1268(2003)008<0225:BNEFOH>2.0.CO;2","article-title":"BAG-1--a nucleotide exchange factor of Hsc70 with multiple cellular functions","volume":"8","author":"Alberti","year":"2003","journal-title":"Cell Stress Chaperones"},{"key":"10.1016\/j.omta.2026.201687_bib27","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1074\/jbc.M706304200","article-title":"HspB8 chaperone activity toward poly(Q)-containing proteins depends on its association with Bag3, a stimulator of macroautophagy","volume":"283","author":"Carra","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omta.2026.201687_bib28","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/emboj.2009.29","article-title":"Protein quality control during aging involves recruitment of the macroautophagy pathway by BAG3","volume":"28","author":"Gamerdinger","year":"2009","journal-title":"EMBO J."},{"key":"10.1016\/j.omta.2026.201687_bib29","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s00109-011-0795-6","article-title":"Emerging roles of molecular chaperones and co-chaperones in selective autophagy: focus on BAG proteins","volume":"89","author":"Gamerdinger","year":"2011","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.omta.2026.201687_bib30","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.4161\/auto.29409","article-title":"BAG3 induces the sequestration of proteasomal clients into cytoplasmic puncta: implications for a proteasome-to-autophagy switch","volume":"10","author":"Minoia","year":"2014","journal-title":"Autophagy"},{"key":"10.1016\/j.omta.2026.201687_bib31","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2014.13","article-title":"RNAi-mediated Gene Silencing of Mutant Myotilin Improves Myopathy in LGMD1A Mice","volume":"3","author":"Liu","year":"2014","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omta.2026.201687_bib32","series-title":"GeneReviews((R))","article-title":"Myofibrillar Myopathy - RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY","author":"Selcen","year":"1993"},{"key":"10.1016\/j.omta.2026.201687_bib33","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1016\/j.jacc.2018.08.2182","article-title":"Cardiac Phenotypes in Hereditary Muscle Disorders: JACC State-of-the-Art Review","volume":"72","author":"Arbustini","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.omta.2026.201687_bib34","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGENETICS.117.001780","article-title":"Novel Mutation in FLNC (Filamin C) Causes Familial Restrictive Cardiomyopathy","volume":"10","author":"Tucker","year":"2017","journal-title":"Circ. Cardiovasc. Genet."},{"key":"10.1016\/j.omta.2026.201687_bib35","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/humu.23248","article-title":"The novel \u03b1B-crystallin (CRYAB) mutation p.D109G causes restrictive cardiomyopathy","volume":"38","author":"Brodehl","year":"2017","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.omta.2026.201687_bib36","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.nmd.2011.07.004","article-title":"A novel CRYAB mutation resulting in multisystemic disease","volume":"22","author":"Sacconi","year":"2012","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.omta.2026.201687_bib37","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.ymgme.2018.01.001","article-title":"Dysregulated autophagy in restrictive cardiomyopathy due to Pro209Leu mutation in BAG3","volume":"123","author":"Schanzer","year":"2018","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.omta.2026.201687_bib38","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/ana.21553","article-title":"Mutation in BAG3 causes severe dominant childhood muscular dystrophy","volume":"65","author":"Selcen","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.omta.2026.201687_bib39","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.nmd.2015.01.009","article-title":"BAG3 myofibrillar myopathy presenting with cardiomyopathy","volume":"25","author":"Konersman","year":"2015","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.omta.2026.201687_bib40","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13023-014-0121-9","article-title":"Unusual multisystemic involvement and a novel BAG3 mutation revealed by NGS screening in a large cohort of myofibrillar myopathies","volume":"9","author":"Semmler","year":"2014","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.omta.2026.201687_bib41","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.jacbts.2022.12.013","article-title":"Bag3 Regulates Mitochondrial Function and the Inflammasome Through Canonical and Noncanonical Pathways in the Heart","volume":"8","author":"Wang","year":"2023","journal-title":"JACC Basic Transl. Sci."},{"key":"10.1016\/j.omta.2026.201687_bib42","first-page":"177","article-title":"BAG3-related myofibrillar myopathy: a further observation with cardiomyopathy at onset in pediatric age","volume":"40","author":"Scarpini","year":"2021","journal-title":"Acta Myol."},{"key":"10.1016\/j.omta.2026.201687_bib43","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1161\/01.RES.0000065442.64694.9F","article-title":"Reengineering inducible cardiac-specific transgenesis with an attenuated myosin heavy chain promoter","volume":"92","author":"Sanbe","year":"2003","journal-title":"Circ. Res."},{"key":"10.1016\/j.omta.2026.201687_bib44","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.3390\/pathogens12111301","article-title":"Transcriptional Targeting Approaches in Cardiac Gene Transfer Using AAV Vectors","volume":"12","author":"Schroder","year":"2023","journal-title":"Pathogens"},{"key":"10.1016\/j.omta.2026.201687_bib45","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-61737-982-6_1","article-title":"Design and testing of regulatory cassettes for optimal activity in skeletal and cardiac muscles","volume":"709","author":"Himeda","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.omta.2026.201687_bib46","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.omtm.2019.09.001","article-title":"A Muscle Hybrid Promoter as a Novel Tool for Gene Therapy","volume":"15","author":"Piekarowicz","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omta.2026.201687_bib47","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/mt.2013.250","article-title":"AAV1.NT-3 gene therapy for charcot-marie-tooth neuropathy","volume":"22","author":"Sahenk","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omta.2026.201687_bib48","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41434-021-00231-3","article-title":"AAV1.NT-3 gene therapy for X-linked Charcot-Marie-Tooth neuropathy type 1","volume":"29","author":"Ozes","year":"2021","journal-title":"Gene Ther."},{"key":"10.1016\/j.omta.2026.201687_bib49","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcab252","article-title":"AAV1.NT-3 gene therapy in a CMT2D model: phenotypic improvements in GarsP278KY\/+ mice","volume":"3","author":"Ozes","year":"2021","journal-title":"Brain Commun."},{"key":"10.1016\/j.omta.2026.201687_bib50","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcae394","article-title":"AAV1.tMCK.NT-3 gene therapy improves phenotype in Sh3tc2-\/- mouse model of Charcot-Marie-Tooth Type 4C","volume":"6","author":"Ozes","year":"2024","journal-title":"Brain Commun."},{"key":"10.1016\/j.omta.2026.201687_bib51","first-page":"1306","article-title":"AAV1.NT-3 gene therapy prevents age-related sarcopenia","volume":"15","author":"Ozes","year":"2023","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.omta.2026.201687_bib52","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1002\/jcsm.13303","article-title":"AAV1.NT-3 gene therapy in the SOD1KO mouse model of accelerated sarcopenia","volume":"14","author":"Tong","year":"2023","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.omta.2026.201687_bib53","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/gt.2015.67","article-title":"AAV1.NT-3 gene therapy attenuates spontaneous autoimmune peripheral polyneuropathy","volume":"23","author":"Yalvac","year":"2016","journal-title":"Gene Ther."},{"key":"10.1016\/j.omta.2026.201687_bib54","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41434-018-0009-8","article-title":"AAV1.NT-3 gene therapy increases muscle fiber diameter through activation of mTOR pathway and metabolic remodeling in a CMT mouse model","volume":"25","author":"Yalvac","year":"2018","journal-title":"Gene Ther."},{"key":"10.1016\/j.omta.2026.201687_bib55","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/s41434-025-00518-9","article-title":"AAV1.NT3 gene therapy mitigates the severity of autoimmune encephalomyelitis in the mouse model for multiple sclerosis","volume":"32","author":"Tong","year":"2025","journal-title":"Gene Ther."},{"key":"10.1016\/j.omta.2026.201687_bib56","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.omtm.2021.06.010","article-title":"Systemic delivery of AAVrh74.tMCK.hCAPN3 rescues the phenotype in a mouse model for LGMD2A\/R1","volume":"22","author":"Sahenk","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."}],"container-title":["Molecular Therapy Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3117387X26000224?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3117387X26000224?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T20:29:45Z","timestamp":1788553785000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S3117387X26000224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S3117387X26000224"],"URL":"https:\/\/doi.org\/10.1016\/j.omta.2026.201687","relation":{},"ISSN":["3117-387X"],"issn-type":[{"value":"3117-387X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autophagy activation via BAG3 gene therapy improves phenotype in a mouse model of LGMD1A","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omta.2026.201687","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"201687"}}